STATUT OR Y INSTRUMENTS 
2024  No. *** 
CONSUMER  PROTECTION 
The Cosmetic  Products  (Restriction  of Chemical  Substances)  (No. 
2) Regulations  2024 
- - - - Made 
Laid befor e Parliament 
Coming  into force with regulation  1(2) 
The Secretary  of State  makes  these  Regulations  in exercise  of powers  conferred  by Article  31(1)(b) 
and Article  31(1)(f)  of Regulation  (EC)  No 1223/2009  of the European  Parliament  and of the 
Council  on cosmetic  products (a). 
Citation,  commencement  and extent 
1. —(1) These  Regulations  may be cited  as the Cosmetic  Products  (Restriction  of Chemical 
Substances)  (No. 2) Regulations  2024. 
(2) These  Regulations  come  into force  21 days after the day on which  they are made. 
(3) These  Regulations  extend  to England  and Wales and Scotland. 
Amendment  to Regulation  (EC)  No 1223/2009 
2. —(1) Regulation  (EC)  No 1223/2009  of the European  Parliament  and of the Council  on 
cosmetic  products  is amended  as follows. 
(2) At the end of the table  in Annex  2 (list of substances  prohibited  in cosmetic  products), 
insert  the entries  set out in Schedule  1 to these  Regulations. 
(3) At the end of the table  in Annex  3 (list of substances  which  cosmetic  products  must  not 
contain  except  subject  to the restrictions  laid down),  insert  the entry  set out in Schedule  2 to 
these  Regulations. 
Transitional  Provision 
3. Notwithstanding  the amendments  in Regulations  2(2) and (3), cosmetic  products  that are 
placed  on the market  on or before  20th April  2025  can continue  to be made  available  on the 
market  on or before  20th August  2025. 
(a) EUR  1223/2009  was incorporated  into domestic  law by virtue  of section  3(1) of the European  Union  (Withdrawal)  Act 
2018  (c. 16) with relevant  amendments  made  by S.I. 2019/696,  S.I. 2022/659,  S.I. 2023/836,  S.I. 2024/[***]. [Placeholder  Name] 
[Placeholder  Title] 
Department  for Business  and Trade 
2 SCHEDULES 
Regulation  2(2) SCHEDULE  1 
Amendments  to Annex  2 
204-126-9 116-14-3 Tetrafluoroethylene 1680 
204-327-1 119-47-1 6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; 
[DBMC] 1681 
692-456-8 688046-61-9 (5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5 
,6-trimethoxy-o-tolyl)methanone;  pyriofenone 1682 
1101132-67-5 (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyeth 
oxy)-o-toluoyl]pyrazol-5-yloxy}ethyl  methyl 
carbonate;  tolpyralate 1683 
215-925-7 1453-58-3 3-methylpyrazole 1684 
1228284-64-7 N-methoxy-N-[1-methyl-2-(2,4,6-trichloroph 
enyl)-ethyl]-3-(difluoromethyl)-1-methylpyra 
zole-4-carboxamide;  Pydiflumetofen 1685 
874967-67-6 N-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}-  3- 
(difluoromethyl)-1-methyl-1Hpyrazole-4-carb 
oxamide;  Sedaxane 1686 
245-740-7 23564-05-8 Thiophanate-methyl  (ISO);  dimethyl  (1,2-  ph 
enylenedicarbamothioyl)biscarbamat;  dimethyl 
4,4’-(o-phenylene)bis(3-  thioallophanate) 1687 
8018-01-7 Mancozeb  (ISO);  manganese 
ethylenebis(dithiocarbamate)  (polymeric) 
complex  with zinc salt 1688 
234-829-6  [1] – 
[2] 12035-72-2  [1] 
12035-71-1  [2] Trinickel  disulfide;  nickel  subsulfide;  [1] 
heazlewoodite  [2] 1689 
203-437-7 106-87-6 7-oxa-3-oxiranylbicyclo[4.1.0]heptane;  1,2-e 
poxy-4-epoxyethylcyclohexane; 
4-vinylcyclohexene  diepoxide 1690 
203-550-1 108-10-1 4-methylpentan-2-one;  isobutyl  methyl  ketone 
(MIBK) 1691 
234-232-0 10605-21-7 Carbendazim  (ISO);  methyl 
benzimidazole-2-ylcarbamat 1692 
404-200-2 110488-70-5; 
(1135441-72-3) Dimethomorph  (ISO);  (E,Z)-4-(3-(4- 
chlorophenyl)-3-(3,4-  dimethoxyphenyl)acryl 
oyl)morpholine 1693 
206-022-9 288-88-0 1,2,4-triazole 1694 
3 103361-09-7 Flumioxazin  (ISO);  N-(7-fluoro-3,4-  dihydro 
-3-oxo-4-prop-2-ynyl-2H-1,4-  benzoxazin-6- 
yl)cyclohex-1-ene-1,2-  dicarboximide 1695 
11431 1-32-9 Imazamox  (ISO);  (RS)-2-(4-isopropyl-4- 
methyl-  5-oxo-2-imidazolin-2-yl)-5- 
methoxymethylnicotinic  acid 1696 
428-650-4 153719-23-4 Thiamethoxam  (ISO);  3-(2-chloro-thiazol-5- 
ylmethyl)-5-  methyl[1,3,5]oxadiazinan-4-ylid 
ene-N-nitroamine 1697 
138182-18-0 Triticonazole  (ISO);  (RS)-(E)-5-(4-  chlorobe 
nzylidene)-2,2-dimethyl-1-(1H1,2,4-triazol-1 
-ylmethyl)cyclopentanol 1698 
237-198-5 13684-56-5 Desmedipham  (ISO);  ethyl  3-phenylcarbamo 
yloxyphenylcarbamate 1699 
231-193-1 7446-07-3 Tellurium  dioxide 1700 
236-813-4 13494-80-9 Tellurium 1701 
607-285-6 2391 10-15-7 Fluopicolide  (ISO); 
2,6-dichloro-N-[3-chloro-5- 
(trifluoromethyl)-2-  pyridylmethyl]benzamide 1702 
216-485-9 1596-84-5 Daminozide  (ISO);  4-(2,2-  dimethylhydrazin 
o)-4-oxobutanoic  acid; 
N-dimethylaminosuccinamic  acid 1703 
204-337-6 119-61-9 Benzophenone 1704 
603-921-1 135410-20-7 Acetamiprid  (ISO);  (1E)-N-[(6- 
chloropyridin-3-  yl)methyl]-N'-cyano-N-meth 1705 
ylethanimidamide;  (E)-N  1 -[(6- 
chloro-3-pyridyl)methyl]-N  2 -cyano-N  1 – 
methylacetamidine 
200-385-7 58-55-9 Theophylline; 
1,3-dimethyl-3,7-dihydro-1 H-purine-2,6-dione 1706 
477-690-9 874819-71-3 N-(2-nitrophenyl)phosphoric  triamide 1707 
213-928-8 1067-33-0 Dibutyltin  di(acetate) 1708 
220-481-2 2781-10-4 Dibutyltin  bis(2-ethylhexanoate) 1709 
202-704-5 98-82-8 Cumene 1710 
237-222-4 13701-59-2 Barium  diboron  tetraoxide 1711 
239-701-3 15625-89-5 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3- 
propanediyldiacrylate;  2,2- 1712 
bis(acryloyloxymethyl)butyl  acrylate; 
trimethylolpropane  triacrylate 
4 220-529-2 2797-51-5 Quinoclamine  (ISO);  2-amino-3-chloro-1,4-n 
aphthoquinone 1713 
254-938-2 40487-42-1 Pendimethalin  (ISO);  N-(1-ethylpropyl)- 
2,6-dinitro-3,4-xylidene 1714 
1255734-28-1 Isoflucypram  (ISO);  N-(5-chloro-2-isopropyl 
benzyl)-N-cyclopropyl-3-(difluoromethyl)-5- 
fluoro-1-methyl-1H-pyrazole-4-carboxamide 1715 
604-712-8 149961-52-4 Dimoxystrobin  (ISO);  (2E)-2-{2-[(2,5-  dime 
thylphenoxy)methyl]phenyl}-2-  (methoxyimi 1716 
no)-N-methylacetamide;  (E)-2-  (methoxyimi 
no)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]ace 
tamide 
203-906-6 111-77-3 2-(2-methoxyethoxy)ethanol;  diethylene  glycol 
monomethyl  ether 1717 
253-057-0 36483-57-5; 
1522-92-5 2,2-dimethylpropan-1-ol,  tribromo  derivative; 
3-bromo-2,2-  bis(bromomethyl)propan-1-ol 1718 
211-989-5 732-26-3 2,4,6-tri-tert-butylphenol 1719 
235-183-8 12124-97-9 Ammonium  bromide 1720 
215-239-8 1314-62-1 Divanadium  pentaoxide;  Vanadium  pentoxide 1721 
246-585-8 25057-89-0 Bentazone  (ISO);  3-isopropyl-2,1,3-  benzoth 
iadiazine-4-one-2,2-dioxide 1722 
283-644-7 84696-25-3 Margosa extract.  [from  the kernels  of 
Azadirachta  indica  extracted  with water  and 
further  processed  with organic  solvents] 1723 
283159-90-0 Valifenalate  (ISO);  methyl  N-(isopropoxycar 
bonyl)-L-valyl-  (3RS)-3- 
(4-chlorophenyl)-β-alaninate 1724 
881685-58-1 Isopyrazam  (ISO);  reaction  mass  of 
3-(difluoromethyl)-1-methyl-N-  [(1RS,4SR,9 1725 
RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-  meth 
anonaphthalen-5-yl]pyrazole-4-carboxamide 
and 3-(difluoromethyl)-1-methyl-N-[(1RS,4S 
R,9SR)-1,2,3,4-  tetrahydro-9-isopropyl-1,4-m 
ethanonaphthalen-5- 
yl]pyrazole-4-carboxamide  [>78%  syn isomers 
≤ 15% anti isomers  relative  content]; 
206-798-9 375-85-9 Perfluoroheptanoic  acid; 
tridecafluoroheptanoic  acid 1726 
201-250-5 80-09-1 4,4’-sulphonyldiphenol;  bisphenol  S 1727 
5 701-1 18-1 2156592-54-8 6-[C10-C13)-alkyl-(branched,  unsaturated)-2 
,5-dioxopyrrolidin-1-yl]hexanoic  acid 
(tetra-PSCA) 1728 
701-162-1 6-[C12-18-alkyl-(branched,  unsaturated)-2,5- 
dioxopyrrolidin-1-yl]hexanoic  acid 
(Penta-PSCA) 1729 
701-271-4 [C12-18-alkyl-(branched,  unsaturated)- 
2,5-dioxopyrrolidin-1-yl]  hexanoic  acid, 1730 
sodium  and tris(2-hydroxyethyl)  ammonium 
salts;  (penta-PSCA  Na-TEA) 
203-615-4 108-78-1 1,3,5-triazine-2,4,6-triamine;  melamine 1731 
Regulation  2(3) SCHEDULE  2 
Amendment  to Annex  3 
1% Face  and hand 
products 207-922-4 501-30-4 Kojic 
acid 5-hydroxy-2-(hydro 
xymethyl)pyran-4-o 
ne 323 
EXPLANA TORY NOTE 
(This  note is not part of the Regulations) 
These  Regulations  amend  assimilated  law, Regulation  (EC)  No 1223/2009  (“the  Cosmetics 
Regulation”),  to prohibit  or restrict  the use of certain  chemical  substances  in cosmetic  products. 
Regulation  2(2) amends  Annex  2 to the Cosmetics  Regulation  to prohibit  the use of chemicals 
in cosmetic  products  following  their classification  as carcinogenic,  mutagenic  or reprotoxic  under 
assimilated  Regulation  (EC)  No 1272/2008.  These  chemicals  are listed  in Schedule  1 to these 
Regulations. 
Regulation  2(3) and Schedule  2 amend  Annex  3 to the Cosmetics  Regulation  to restrict  the use 
of kojic  acid in cosmetic  products. 
Regulation  3 sets out the transitional  arrangement  for cosmetic  products  containing  the chemical 
substances  detailed  in the Schedules  to these  Regulations  and provides  that where  products  are 
placed  on the market  on or before  20th April  2025,  they can continue  to be made  available  on 
the market  on or before  20th August  2025. 
[A full impact  assessment  has not been  produced  for this instrument  as no, or no significant, 
impact  on the private,  voluntary  or business  sectors  is foreseen.  An Explanatory  Memorandum 
has been  published  alongside  these  Regulations  and is available  at www .legislation.gov .uk.] 
6